Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.62 USD | +0.85% | +0.19% | -5.18% |
04-11 | Craig-Hallum Starts Harrow With Buy Rating, $24 Price Target | MT |
03-22 | B. Riley Securities Adjusts Harrow Health's Price Target to $26 From $30, Maintains Buy Rating | MT |
Business Summary
Number of employees: 315
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Innovative Ophthalmic Therapies
100.0
%
| 89 | 100.0 % | 130 | 100.0 % | +46.95% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 89 | 100.0 % | 130 | 100.0 % | +46.95% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mark Baum
CEO | Chief Executive Officer | 51 | 31/12/05 |
Andrew Boll
DFI | Director of Finance/CFO | 41 | 30/11/11 |
Jamie Webb
IRC | Investor Relations Contact | - | - |
Kim Barratt
HRO | Human Resources Officer | - | 30/06/22 |
Dennis E. Saadeh
PRN | Corporate Officer/Principal | - | - |
Mark Mannebach
LAW | General Counsel | - | 05/03/23 |
John Saharek
PRN | Corporate Officer/Principal | 64 | 31/10/12 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Baum
CEO | Chief Executive Officer | 51 | 31/12/05 |
Director/Board Member | 65 | 01-25 | |
Adrienne Graves
BRD | Director/Board Member | 69 | 01-25 |
Teresa Sparks
BRD | Director/Board Member | 55 | 15/03/20 |
Director/Board Member | 55 | 30/03/22 | |
Marty Makary
BRD | Director/Board Member | 53 | 30/03/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 35,362,642 | 30,204,168 ( 85.41 %) | 0 | 85.41 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
1,982,000 | 7.72% | 7,432,500 $ |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.18% | 372M | |
+26.47% | 661B | |
+26.74% | 566B | |
-6.33% | 352B | |
+19.35% | 332B | |
+4.23% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.04% | 145B |
- Stock Market
- Equities
- HROW Stock
- Company Harrow, Inc.